CFO
IDXX icon

Callan Family Office’s Idexx Laboratories IDXX Stock Holding History

Callan Family Office’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
3,531
-790
-18% -$443K 0.04% 418
2026
Q1 		$2.43M Sell
4,321
-325
-7% -$208K 0.06% 303
2025
Q4 		$3.14M Buy
4,646
+2,572
+124% +$1.75M 0.07% 259
2025
Q3 		$1.33M Sell
2,074
-412
-17% -$250K 0.04% 333
2025
Q2 		$1.33M Buy
2,486
+1,939
+354% +$927K 0.04% 344
2025
Q1 		$230K Sell
547
-49
-8% -$21.3K 0.02% 498
2024
Q4 		$246K Buy
+596
New +$261K 0.02% 543

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Callan Family Office's IDXX Position: Q2 2026 in Review

Callan Family Office reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $443K and leaving 3,531 shares worth $1.86M. The position accounts for 0.04% of the portfolio, ranked #418.

Callan Family Office first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.14M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Callan Family Office held 3,531 shares of Idexx Laboratories worth $1.86M as of Q2 2026.
  • Callan Family Office sold 790 Idexx Laboratories shares in Q2 2026, an estimated $443K.
  • Idexx Laboratories made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #418 holding.
  • Callan Family Office first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Idexx Laboratories position peaked at $3.14M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.